Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 127

1.

Outcomes of Hematopoietic Cell Transplantation in Patients with Germline SAMD9/SAMD9L Mutations.

Ahmed IA, Farooqi MS, Vander Lugt MT, Boklan J, Rose M, Friehling ED, Triplett B, Lieuw K, Saldana BD, Smith CM, Schwartz JR, Goyal RK.

Biol Blood Marrow Transplant. 2019 Jul 12. pii: S1083-8791(19)30439-2. doi: 10.1016/j.bbmt.2019.07.007. [Epub ahead of print]

PMID:
31306780
2.

Scalp Condition Impacts Hair Growth and Retention via Oxidative Stress.

Trüeb RM, Henry JP, Davis MG, Schwartz JR.

Int J Trichology. 2018 Nov-Dec;10(6):262-270. doi: 10.4103/ijt.ijt_57_18. Review.

3.

Donor-derived MDS/AML in families with germline GATA2 mutation.

Galera P, Hsu AP, Wang W, Droll S, Chen R, Schwartz JR, Klco JM, Arai S, Maese L, Zerbe C, Parta MJ, Young NS, Holland SM, Hickstein DD, Calvo KR.

Blood. 2018 Nov 1;132(18):1994-1998. doi: 10.1182/blood-2018-07-861070. Epub 2018 Sep 19. No abstract available.

4.

Clonal dynamics of donor-derived myelodysplastic syndrome after unrelated hematopoietic cell transplantation for high-risk pediatric B-lymphoblastic leukemia.

Schwartz JR, Walsh MP, Ma J, Lamprecht T, Wang S, Wu G, Raimondi S, Triplett BM, Klco JM.

Cold Spring Harb Mol Case Stud. 2018 Oct 1;4(5). pii: a002980. doi: 10.1101/mcs.a002980. Print 2018 Oct.

5.

The genomic landscape of pediatric myelodysplastic syndromes.

Schwartz JR, Ma J, Lamprecht T, Walsh M, Wang S, Bryant V, Song G, Wu G, Easton J, Kesserwan C, Nichols KE, Mullighan CG, Ribeiro RC, Klco JM.

Nat Commun. 2017 Nov 16;8(1):1557. doi: 10.1038/s41467-017-01590-5.

6.

Incubatory environment of the scalp impacts pre-emergent hair to affect post-emergent hair cuticle integrity.

Schwartz JR, Henry JP, Kerr KM, Flagler MJ, Page SH, Redman-Furey N.

J Cosmet Dermatol. 2018 Feb;17(1):105-111. doi: 10.1111/jocd.12355. Epub 2017 May 14.

PMID:
28504468
7.

Germline SAMD9 mutation in siblings with monosomy 7 and myelodysplastic syndrome.

Schwartz JR, Wang S, Ma J, Lamprecht T, Walsh M, Song G, Raimondi SC, Wu G, Walsh MF, McGee RB, Kesserwan C, Nichols KE, Cauff BE, Ribeiro RC, Wlodarski M, Klco JM.

Leukemia. 2017 Aug;31(8):1827-1830. doi: 10.1038/leu.2017.142. Epub 2017 May 10. No abstract available.

8.

DAT-positive Plasmodium ovale malaria presenting in a child with sickle cell anemia.

Whipple NS, Schwartz JR, Nottage KA.

Am J Hematol. 2017 Jul;92(7):722. doi: 10.1002/ajh.24691. Epub 2017 Mar 22. No abstract available.

9.

Zinc Pyrithione: A Topical Antimicrobial With Complex Pharmaceutics.

Schwartz JR.

J Drugs Dermatol. 2016 Feb;15(2):140-4. Review.

PMID:
26885780
10.

The role of oxidative damage in poor scalp health: ramifications to causality and associated hair growth.

Schwartz JR, Henry JP, Kerr KM, Mizoguchi H, Li L.

Int J Cosmet Sci. 2015 Dec;37 Suppl 2:9-15. doi: 10.1111/ics.12289.

PMID:
26574300
11.

Epigenetic alteration by DNA-demethylating treatment restores apoptotic response to glucocorticoids in dexamethasone-resistant human malignant lymphoid cells.

Miller AL, Geng C, Golovko G, Sharma M, Schwartz JR, Yan J, Sowers L, Widger WR, Fofanov Y, Vedeckis WV, Thompson EB.

Cancer Cell Int. 2014 Apr 23;14:35. doi: 10.1186/1475-2867-14-35. eCollection 2014.

12.

Therapeutic efficacy of anti-dandruff shampoos: a randomized clinical trial comparing products based on potentiated zinc pyrithione and zinc pyrithione/climbazole.

Schwartz JR, Bacon RA, Shah R, Mizoguchi H, Tosti A.

Int J Cosmet Sci. 2013 Aug;35(4):381-7. doi: 10.1111/ics.12055. Epub 2013 May 24.

PMID:
23614401
13.

A comprehensive pathophysiology of dandruff and seborrheic dermatitis - towards a more precise definition of scalp health.

Schwartz JR, Messenger AG, Tosti A, Todd G, Hordinsky M, Hay RJ, Wang X, Zachariae C, Kerr KM, Henry JP, Rust RC, Robinson MK.

Acta Derm Venereol. 2013 Mar 27;93(2):131-7. doi: 10.2340/00015555-1382.

14.

Assessing therapeutic effectiveness of scalp treatments for dandruff and seborrheic dermatitis, part 2: the impact of gender and ethnicity on efficacy.

Bacon RA, Mizoguchi H, Schwartz JR.

J Dermatolog Treat. 2014 Jun;25(3):237-40. doi: 10.3109/09546634.2012.719077. Epub 2012 Sep 19.

PMID:
22866664
15.

Role of c-Myb in the survival of pre B-cell acute lymphoblastic leukemia and leukemogenesis.

Sarvaiya PJ, Schwartz JR, Hernandez CP, Rodriguez PC, Vedeckis WV.

Am J Hematol. 2012 Oct;87(10):969-76. doi: 10.1002/ajh.23283. Epub 2012 Jul 5.

16.

A facile, branched DNA assay to quantitatively measure glucocorticoid receptor auto-regulation in T-cell acute lymphoblastic leukemia.

Schwartz JR, Sarvaiya PJ, Leiva LE, Velez MC, Singleton TC, Yu LC, Vedeckis WV.

Chin J Cancer. 2012 Aug;31(8):381-91. doi: 10.5732/cjc.012.10044. Epub 2012 Jun 26.

17.

c-Myb interacts with the glucocorticoid receptor and regulates its level in pre-B-acute lymphoblastic leukemia cells.

Sarvaiya PJ, Schwartz JR, Geng CD, Vedeckis WV.

Mol Cell Endocrinol. 2012 Sep 25;361(1-2):124-32. doi: 10.1016/j.mce.2012.03.024. Epub 2012 Apr 10.

18.

Assessing therapeutic effectiveness of scalp treatments for dandruff and seborrheic dermatitis, part 1: a reliable and relevant method based on the adherent scalp flaking score (ASFS).

Bacon RA, Mizoguchi H, Schwartz JR.

J Dermatolog Treat. 2014 Jun;25(3):232-6. doi: 10.3109/09546634.2012.687089. Epub 2012 Jun 12.

PMID:
22515728
19.

Zinc pyrithione inhibits yeast growth through copper influx and inactivation of iron-sulfur proteins.

Reeder NL, Kaplan J, Xu J, Youngquist RS, Wallace J, Hu P, Juhlin KD, Schwartz JR, Grant RA, Fieno A, Nemeth S, Reichling T, Tiesman JP, Mills T, Steinke M, Wang SL, Saunders CW.

Antimicrob Agents Chemother. 2011 Dec;55(12):5753-60. doi: 10.1128/AAC.00724-11. Epub 2011 Sep 26.

20.

New insights on dandruff/seborrhoeic dermatitis: the role of the scalp follicular infundibulum in effective treatment strategies.

Schwartz JR, Shah R, Krigbaum H, Sacha J, Vogt A, Blume-Peytavi U.

Br J Dermatol. 2011 Oct;165 Suppl 2:18-23. doi: 10.1111/j.1365-2133.2011.10573.x.

PMID:
21919899
21.

The antifungal mechanism of action of zinc pyrithione.

Reeder NL, Xu J, Youngquist RS, Schwartz JR, Rust RC, Saunders CW.

Br J Dermatol. 2011 Oct;165 Suppl 2:9-12. doi: 10.1111/j.1365-2133.2011.10571.x.

PMID:
21919897
22.

Dexamethasone premedication for prophylaxis of taxane toxicities: can the doses be reduced when paclitaxel or docetaxel are given weekly?

Schwartz JR.

J Oncol Pharm Pract. 2012 Jun;18(2):250-6. doi: 10.1177/1078155211409473. Epub 2011 Aug 1. Review.

PMID:
21807762
23.

Scalp stratum corneum histamine levels: novel sampling method reveals association with itch resolution in dandruff/seborrhoeic dermatitis treatment.

Kerr K, Schwartz JR, Filloon T, Fieno A, Wehmeyer K, Szepietowski JC, Mills KJ.

Acta Derm Venereol. 2011 Jun;91(4):404-8. doi: 10.2340/00015555-1073.

24.

Epidermal changes associated with symptomatic resolution of dandruff: biomarkers of scalp health.

Kerr K, Darcy T, Henry J, Mizoguchi H, Schwartz JR, Morrall S, Filloon T, Wimalasena R, Fadayel G, Mills KJ.

Int J Dermatol. 2011 Jan;50(1):102-13. doi: 10.1111/j.1365-4632.2010.04629.x.

PMID:
21182510
26.

Armodafinil in the treatment of sleep/wake disorders.

Schwartz JR, Roth T, Drake C.

Neuropsychiatr Dis Treat. 2010 Sep 7;6:417-27.

27.

Glucocorticoid receptor knock down reveals a similar apoptotic threshold but differing gene regulation patterns in T-cell and pre-B-cell acute lymphoblastic leukemia.

Schwartz JR, Sarvaiya PJ, Vedeckis WV.

Mol Cell Endocrinol. 2010 May 14;320(1-2):76-86. doi: 10.1016/j.mce.2010.02.014. Epub 2010 Feb 17.

28.

Utility and safety of axillo-subclavian venous imaging with carbon dioxide (CO) prior to chronic lead system revisions.

Winters SL, Curwin JH, Sussman JS, Coyne RF, Calhoun SK, Yablonsky TM, Schwartz JR, Quinlan K.

Pacing Clin Electrophysiol. 2010 Jul;33(7):790-4. doi: 10.1111/j.1540-8159.2009.02680.x. Epub 2010 Jan 28.

PMID:
20132493
29.

Recognition of shift-work disorder in primary care.

Schwartz JR.

J Fam Pract. 2010 Jan;59(1 Suppl):S18-23. Review.

PMID:
20074506
30.

Recognition and management of excessive sleepiness in the primary care setting.

Schwartz JR, Roth T, Hirshkowitz M, Wright KP.

Prim Care Companion J Clin Psychiatry. 2009;11(5):197-204. doi: 10.4088/PCC.07r00545.

31.

Modafinil in the treatment of excessive sleepiness.

Schwartz JR.

Drug Des Devel Ther. 2009 Feb 6;2:71-85.

32.

A first-order simulator to control dioxin emissions: NMCRC-ATMOS.

Schwartz JR, Mark S, Wolfson A.

Waste Manag Res. 2010 May;28(5):461-71. doi: 10.1177/0734242X09337660. Epub 2009 Sep 11.

PMID:
19748934
33.

Neurophysiology of sleep and wakefulness: basic science and clinical implications.

Schwartz JR, Roth T.

Curr Neuropharmacol. 2008 Dec;6(4):367-78. doi: 10.2174/157015908787386050.

34.

Dandruff and seborrheic dermatitis adversely affect hair quality.

Sinclair RD, Schwartz JR, Rocchetta HL, Dawson TL Jr, Fisher BK, Meinert K, Wilder EA.

Eur J Dermatol. 2009 Jul-Aug;19(4):410-1. doi: 10.1684/ejd.2009.0708. Epub 2009 May 26. No abstract available.

PMID:
19467978
35.

Does tachyphylaxis occur in long-term management of scalp seborrheic dermatitis with pyrithione zinc-based treatments?

Schwartz JR, Rocchetta H, Asawanonda P, Luo F, Thomas JH.

Int J Dermatol. 2009 Jan;48(1):79-85. doi: 10.1111/j.1365-4632.2009.03794.x.

PMID:
19126058
36.

A conserved molecular mechanism is responsible for the auto-up-regulation of glucocorticoid receptor gene promoters.

Geng CD, Schwartz JR, Vedeckis WV.

Mol Endocrinol. 2008 Dec;22(12):2624-42. doi: 10.1210/me.2008-0157. Epub 2008 Oct 22.

37.

Pharmacologic therapy for sleep-related breathing disorders.

Schwartz JR, Hughes RJ, Roth T.

Expert Rev Clin Pharmacol. 2008 May;1(3):441-55. doi: 10.1586/17512433.1.3.441.

PMID:
24422697
38.

Evaluation of the safety of modafinil for treatment of excessive sleepiness.

Roth T, Schwartz JR, Hirshkowitz M, Erman MK, Dayno JM, Arora S.

J Clin Sleep Med. 2007 Oct 15;3(6):595-602.

39.

Shift work sleep disorder: burden of illness and approaches to management.

Schwartz JR, Roth T.

Drugs. 2006;66(18):2357-70. Review.

PMID:
17181377
40.

Does the platinum-free interval predict the incidence or severity of hypersensitivity reactions to carboplatin? The experience from Women and Infants' Hospital.

Schwartz JR, Bandera C, Bradley A, Brard L, Legare R, Granai CO, Dizon DS.

Gynecol Oncol. 2007 Apr;105(1):81-3. Epub 2006 Dec 8.

PMID:
17157366
41.

Three etiologic facets of dandruff and seborrheic dermatitis: Malassezia fungi, sebaceous lipids, and individual sensitivity.

DeAngelis YM, Gemmer CM, Kaczvinsky JR, Kenneally DC, Schwartz JR, Dawson TL Jr.

J Investig Dermatol Symp Proc. 2005 Dec;10(3):295-7.

42.

Product pharmacology and medical actives in achieving therapeutic benefits.

Schwartz JR.

J Investig Dermatol Symp Proc. 2005 Dec;10(3):198-200. No abstract available.

43.

Dose effects of modafinil in sustaining wakefulness in narcolepsy patients with residual evening sleepiness.

Schwartz JR, Feldman NT, Bogan RK.

J Neuropsychiatry Clin Neurosci. 2005 Summer;17(3):405-12. Erratum in: J Neuropsychiatry Clin Neurosci. 2005 Fall;17(4):561.

PMID:
16179665
44.

Modafinil for excessive sleepiness associated with shift-work sleep disorder.

Czeisler CA, Walsh JK, Roth T, Hughes RJ, Wright KP, Kingsbury L, Arora S, Schwartz JR, Niebler GE, Dinges DF; U.S. Modafinil in Shift Work Sleep Disorder Study Group.

N Engl J Med. 2005 Aug 4;353(5):476-86. Erratum in: N Engl J Med. 2005 Sep 8;353(10):1078.

45.

Zinc and skin health: overview of physiology and pharmacology.

Schwartz JR, Marsh RG, Draelos ZD.

Dermatol Surg. 2005 Jul;31(7 Pt 2):837-47; discussion 847. Review.

PMID:
16029676
46.

Modafinil: new indications for wake promotion.

Schwartz JR.

Expert Opin Pharmacother. 2005 Jan;6(1):115-29. Review.

PMID:
15709889
47.

Closing ... closing ... closed.

Peregrine MW, Schwartz JR.

Trustee. 2001 Jan;54(1):18-21, 1.

PMID:
15700501
48.

Pharmacologic management of daytime sleepiness.

Schwartz JR.

J Clin Psychiatry. 2004;65 Suppl 16:46-9.

49.

Pardon me: that's our money!

Peregrine MW, Schwartz JR.

Healthc Financ Manage. 2004 Oct;58(10):58-62, 64.

PMID:
15524035
50.

Effects of modafinil on wakefulness and executive function in patients with narcolepsy experiencing late-day sleepiness.

Schwartz JR, Nelson MT, Schwartz ER, Hughes RJ.

Clin Neuropharmacol. 2004 Mar-Apr;27(2):74-9. Erratum in: Clin Neuropharmacol. 2004 May-Jun;27(3):152.

PMID:
15252267

Supplemental Content

Loading ...
Support Center